Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10
NCT00000345 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2017-01-12
Summary
The purpose of this study is to assess the safety of lofexidine in the treatment of opiate-dependent individuals.
Conditions
- Opioid-Related Disorders
Interventions
- DRUG
-
Lofexidine
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
lead NIH
Principal Investigators
-
Walter Ling, M.D. · Friends Research Institute, Inc.
Study Design
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 21 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1996-04-30
Countries
- United States
Study Locations
More Related Trials
-
Buprenorphine Maintenance for Opioid Addicts - 2
NCT00000203 ·Status: COMPLETED ·Phase: PHASE2
-
Activity Monitoring Assessment of Opiate Withdrawal - 4
NCT00000335 ·Status: COMPLETED ·Phase: PHASE2
-
Buprenorphine Maintenance for Opioid Addicts - 1
NCT00000202 ·Status: COMPLETED ·Phase: PHASE2
-
Development of an Opioid Withdrawal Clinical Outcome Assessment
NCT07094672 ·Status: NOT_YET_RECRUITING
-
Smartphones for Opiate Addiction Recovery
NCT05033028 ·Status: RECRUITING ·Phase: PHASE3
-
A Laboratory Model for Heroin Abuse Medications - 8
NCT00000273 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating a Novel Medication Device for Methadone Dosing
NCT03254043 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine Maintenance Protocol - 1
NCT00000205 ·Status: COMPLETED ·Phase: PHASE3
-
Galantamine and CBT4CBT Pilot to Prevent Relapse.
NCT03547622 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on Methadone
NCT00000243 ·Status: TERMINATED ·Phase: NA
-
Evaluating Buspirone to Treat Opioid Withdrawal
NCT05511909 ·Status: RECRUITING ·Phase: PHASE2
-
Evaluation of a Novel Intervention to Prevent Polysubstance Overdoses Involving Illicit Stimulants
NCT05493475 ·Status: COMPLETED ·Phase: NA
-
Variance of Oral Methadone Dosage: Description of Implicated Factors
NCT00894452 ·Status: COMPLETED
-
Buprenorphine Maintenance for Opioid Addicts - 3
NCT00000204 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care
NCT00471042 ·Status: COMPLETED
-
Aprepitant Effects in Intravenous Heroin Dependence
NCT01527994 ·Status: COMPLETED ·Phase: PHASE1
-
Opioid Treatment Program (OTP)-Pharmacy Collaboration for Methadone Maintenance Treatment
NCT04308694 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry
NCT01999946 ·Status: COMPLETED ·Phase: PHASE4
-
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2
NCT00000319 ·Status: COMPLETED ·Phase: PHASE2
-
Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections
NCT04677114 ·Status: COMPLETED ·Phase: PHASE2
-
Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy
NCT05251376 ·Status: WITHDRAWN ·Phase: PHASE1
-
Using mHealth to Aid Opioid Medication Adherence Pilot Study
NCT02017041 ·Status: COMPLETED
-
Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1
NCT00000318 ·Status: COMPLETED ·Phase: PHASE2
-
Memantine and Naltrexone Treatment for Opioid Dependence
NCT00125515 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Buprenorphine and Methadone - 3
NCT00000334 ·Status: COMPLETED ·Phase: PHASE2